172 related articles for article (PubMed ID: 38847579)
1. Viral strategies to antagonize the host antiviral innate immunity: an indispensable research direction for emerging virus-host interactions.
Chen N; Jin J; Zhang B; Meng Q; Lu Y; Liang B; Deng L; Qiao B; Zheng L
Emerg Microbes Infect; 2024 Dec; 13(1):2341144. PubMed ID: 38847579
[TBL] [Abstract][Full Text] [Related]
2. Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2.
Chen N; Zhang B; Deng L; Liang B; Ping J
Emerg Microbes Infect; 2022 Dec; 11(1):1371-1389. PubMed ID: 35476817
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.
Oh SJ; Shin OS
J Microbiol; 2022 Mar; 60(3):290-299. PubMed ID: 35122601
[TBL] [Abstract][Full Text] [Related]
5. Regulation of SARS-CoV-2 infection and antiviral innate immunity by ubiquitination and ubiquitin-like conjugation.
Zheng Y; Yang H; Zhang X; Gao C
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194984. PubMed ID: 37717938
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2.
Xia H; Shi PY
J Interferon Cytokine Res; 2020 Dec; 40(12):543-548. PubMed ID: 33337934
[TBL] [Abstract][Full Text] [Related]
7. Human Nasal and Lung Tissues Infected
Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
[TBL] [Abstract][Full Text] [Related]
8. Insights into pandemic respiratory viruses: manipulation of the antiviral interferon response by SARS-CoV-2 and influenza A virus.
Liu G; Gack MU
Curr Opin Immunol; 2022 Oct; 78():102252. PubMed ID: 36215931
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.
Gu W; Gan H; Ma Y; Xu L; Cheng ZJ; Li B; Zhang X; Jiang W; Sun J; Sun B; Hao C
Virol J; 2022 Mar; 19(1):49. PubMed ID: 35305698
[TBL] [Abstract][Full Text] [Related]
10. IFN Regulatory Factors and Antiviral Innate Immunity: How Viruses Can Get Better.
Marsili G; Perrotti E; Remoli AL; Acchioni C; Sgarbanti M; Battistini A
J Interferon Cytokine Res; 2016 Jul; 36(7):414-32. PubMed ID: 27379864
[TBL] [Abstract][Full Text] [Related]
11. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D
Cells; 2021 Jul; 10(7):. PubMed ID: 34359926
[TBL] [Abstract][Full Text] [Related]
13. Viral Protein Accumulation of Zika Virus Variants Links with Regulation of Innate Immunity for Differential Control of Viral Replication, Spread, and Response to Interferon.
Lu AY; Gustin A; Newhouse D; Gale M
J Virol; 2023 May; 97(5):e0198222. PubMed ID: 37162358
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional and Non-Transcriptional Activation, Posttranslational Modifications, and Antiviral Functions of Interferon Regulatory Factor 3 and Viral Antagonism by the SARS-Coronavirus.
Glanz A; Chakravarty S; Varghese M; Kottapalli A; Fan S; Chakravarti R; Chattopadhyay S
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805458
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
Wang W; Zhou Z; Xiao X; Tian Z; Dong X; Wang C; Li L; Ren L; Lei X; Xiang Z; Wang J
Cell Mol Immunol; 2021 Apr; 18(4):945-953. PubMed ID: 33637958
[TBL] [Abstract][Full Text] [Related]
16. XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity.
Han Y; Bai X; Liu S; Zhu J; Zhang F; Xie L; Liu G; Jiang X; Zhang M; Huang Y; Wang J; Li D; Zhang H; He Y; He S; Xia Y; Xu X; Xu F; Ma F
J Virol; 2022 Sep; 96(17):e0077422. PubMed ID: 35972291
[TBL] [Abstract][Full Text] [Related]
17. Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection.
Lin MH; Li D; Tang B; Li L; Suhrbier A; Harrich D
Microbiol Spectr; 2022 Dec; 10(6):e0394922. PubMed ID: 36445148
[TBL] [Abstract][Full Text] [Related]
18. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.
Zhang J; Zhao C; Zhao W
Front Immunol; 2021; 12():633769. PubMed ID: 33912161
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons
Luo W; Huang L; Wang X; Ma Y; Xiao J; Song X; Liu P; Wang Y; Wang Y; Ren Z
Int J Med Sci; 2021; 18(12):2561-2569. PubMed ID: 34104087
[TBL] [Abstract][Full Text] [Related]
20. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
Shin D; Mukherjee R; Grewe D; Bojkova D; Baek K; Bhattacharya A; Schulz L; Widera M; Mehdipour AR; Tascher G; Geurink PP; Wilhelm A; van der Heden van Noort GJ; Ovaa H; Müller S; Knobeloch KP; Rajalingam K; Schulman BA; Cinatl J; Hummer G; Ciesek S; Dikic I
Nature; 2020 Nov; 587(7835):657-662. PubMed ID: 32726803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
